Adam Anderson, the Chief Executive Officer of $INVX, sold 13,241 shares of the company on 02-23-2026 for an estimated $357,507. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.7% of their shares of this class of stock. Following this trade, they now own 485,581 shares of this class of $INVX stock.
$INVX Insider Trading Activity
$INVX insiders have traded $INVX stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $INVX stock by insiders over the last 6 months:
- ADAM ANDERSON (Chief Executive Officer) has made 0 purchases and 2 sales selling 26,482 shares for an estimated $688,532.
- MARK REDDOUT (President of North America) sold 20,000 shares for an estimated $500,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$INVX Hedge Fund Activity
We have seen 97 institutional investors add shares of $INVX stock to their portfolio, and 97 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MADISON AVENUE PARTNERS, LP removed 1,767,997 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $32,778,664
- SG AMERICAS SECURITIES, LLC added 580,795 shares (+inf%) to their portfolio in Q4 2025, for an estimated $12,701,986
- VICTORY CAPITAL MANAGEMENT INC added 570,014 shares (+628.3%) to their portfolio in Q4 2025, for an estimated $12,466,206
- PACER ADVISORS, INC. removed 388,523 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $8,496,998
- WELLINGTON MANAGEMENT GROUP LLP removed 375,340 shares (-15.4%) from their portfolio in Q4 2025, for an estimated $8,208,685
- AVIDIAN WEALTH ENTERPRISES, LLC added 266,162 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,820,962
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 261,597 shares (-73.2%) from their portfolio in Q4 2025, for an estimated $5,721,126
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$INVX Revenue
$INVX had revenues of $273.6M in Q4 2025. This is an increase of 9.14% from the same period in the prior year.
You can track INVX financials on Quiver Quantitative's INVX stock page.
$INVX Congressional Stock Trading
Members of Congress have traded $INVX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $INVX stock by members of Congress over the last 6 months:
- REPRESENTATIVE DEBBIE WASSERMAN SCHULTZ sold up to $0 on 11/25.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$INVX Analyst Ratings
Wall Street analysts have issued reports on $INVX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 12/18/2025
To track analyst ratings and price targets for $INVX, check out Quiver Quantitative's $INVX forecast page.
$INVX Price Targets
Multiple analysts have issued price targets for $INVX recently. We have seen 2 analysts offer price targets for $INVX in the last 6 months, with a median target of $23.5.
Here are some recent targets:
- Derek Podhaizer from Piper Sandler set a target price of $27.0 on 12/18/2025
- Eddie Kim from Barclays set a target price of $20.0 on 11/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
